Does Exemestane (steroidal aromatase inhibitor) contain steroids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Exemestane Contain Steroids?

Yes, exemestane is itself a steroidal compound—specifically, a steroidal aromatase inhibitor with a chemical structure derived from androstenedione. 1, 2

Chemical Structure and Classification

Exemestane is chemically described as 6-methylenandrosta-1,4-diene-3,17-dione, making it structurally related to the natural androgen substrate androstenedione. 2 This steroidal structure is fundamental to how the drug works and distinguishes it from nonsteroidal aromatase inhibitors like anastrozole and letrozole. 1

Mechanism Related to Steroidal Nature

The steroidal structure of exemestane allows it to act as a "false substrate" for the aromatase enzyme. 2 Specifically:

  • Exemestane binds irreversibly to the catalytic site of aromatase, causing permanent enzyme inactivation through a mechanism called "suicide inhibition" 1, 2
  • This contrasts with nonsteroidal aromatase inhibitors (letrozole, anastrozole), which bind reversibly to the heme group of the enzyme 1
  • The irreversible binding contributes to sustained estrogen suppression that persists for 4-5 days after a single dose 2

Clinical Implications of Its Steroidal Nature

Because exemestane has androgenic properties due to its steroidal structure, researchers initially hypothesized it might have less impact on bone loss compared to nonsteroidal aromatase inhibitors. 1 However, clinical trial data from the Intergroup Exemestane Study (IES) showed that fracture incidence at 58 months was actually significantly higher with exemestane (7%) compared to tamoxifen (5%), dispelling this hypothesis. 1

The NCCN Breast Cancer Guidelines Panel considers all three selective aromatase inhibitors (anastrozole, letrozole, exemestane) to be similar in antitumor activity and toxicity profiles, despite the structural difference between steroidal and nonsteroidal agents. 1

Important Clarification

While exemestane is a steroid by chemical structure, it does not contain corticosteroids or anabolic steroids in the traditional sense that patients often worry about. 2 Exemestane has no detectable effect on adrenal biosynthesis of corticosteroids or aldosterone, and has no effect on other enzymes involved in the steroidogenic pathway up to concentrations at least 600 times higher than those that inhibit aromatase. 2

Practical Considerations

  • The steroidal nature of exemestane means it may be tried after failure of nonsteroidal aromatase inhibitors (or vice versa), as cross-resistance is not complete 3, 4
  • Androgenic events have been reported in a small number of patients receiving high doses (200 mg daily) but are rarely reported at the recommended 25 mg daily dosage 4, 5
  • The drug's steroidal structure does not translate to the side effects typically associated with corticosteroid or anabolic steroid use 4, 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternative Treatments to Anastrozole for Elevated Estrogen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Exemestane.

Drugs, 1999

Research

Exemestane in advanced breast cancer.

Anti-cancer drugs, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.